Arkolith/Insider Trading/NAVB/Form 4

Scott John K Jr.

Director, 10% OwnerNAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) · full profile →Form 4 · filed Jun 30, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2023Grant(A)12.2M$0.09$1.1M31.8M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-23-018979) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML